Mammotome Revolve Dual Vacuum Assist Biopsy System The device is used to sample breast tissue that has been identified as suspicious under imaging guidance
Published March 29, 2017 · Recall initiated: February 28, 2017
Summary
FDA records medical device Class II recall Z-1512-2017, published March 29, 2017 and initiated February 28, 2017. Recalling firm: Devicor Medical Products Inc; Status: Terminated; Reported quantity: 320; Lot: F11621304D1. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
The device did not have Revolve Stereo Probe labeling, no product code indicating the size and length of the probe, no sterilization sticker or lot number.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Devicor Medical Products Inc
- Distributor
- Worldwide Distribution - US including IA, IL, NY, OH, OK, PA, TN & WV. Internationally to Chile and Brazil
- Lot
- F11621304D1
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDAHydroMARK Breast Biopsy Site Marker, Model Number: 4010-02-15-T3June 3, 2026
- FDACarePlus Incubator Ohmeda-Ohio CarePlus Incubator- Incubators provide a controlled thermal environment forMarch 29, 2017
- FDAPoly Component Trial, UCCS, packaged in the following sizes and configurations: a) Poly Comp Trial - UCCSMarch 29, 2017
- FDAGiraffe Bedded Warmer, Panda Warmer Modifiction to Giraffe and Panda Warmer- Infant radiant warmers provideMarch 29, 2017
- FDAMerge Cardio software. Product Usage: Merge Cardio is a system intended to be used to acquire, store, print,March 29, 2017
- FDAGiraffe Bedded Warmer, Panda Warmer Modification to Giraffe and Panda Warmers (Giraffe and PandaMarch 29, 2017
Questions about this recall
Was Mammotome Revolve Dual Vacuum Assist Biopsy System The device is used to sample breast tissue that has been identified as suspicious under imaging guidance recalled?
Yes. FDA published recall Z-1512-2017 on March 29, 2017. Reported hazard: The device did not have Revolve Stereo Probe labeling, no product code indicating the size and length of the probe, no sterilization sticker or lot number.
What should I do if I have this product?
Voluntary: Firm initiated · Letter